Unveiling ferroptosis: a new frontier in skin disease research DOI Creative Commons
Ke Wang,

Yumeng Lin,

Dan Zhou

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Окт. 4, 2024

Ferroptosis, a form of regulated cell death distinct from apoptosis, necrosis, and autophagy, is increasingly recognized for its role in skin disease pathology. Characterized by iron accumulation lipid peroxidation, ferroptosis has been implicated the progression various conditions, including psoriasis, photosensitive dermatitis, melanoma. This review provides an in-depth analysis molecular mechanisms underlying compares cellular effects with other forms context health disease. We systematically examine five specific diseases, ichthyosis, polymorphous light eruption (PMLE), vitiligo, melanoma, detailing influence on pathogenesis progression. Moreover, we explore current clinical landscape ferroptosis-targeted therapies, discussing their potential managing treating diseases. Our aim to shed therapeutic modulating research practice.

Язык: Английский

Ferroptosis: mechanisms and therapeutic targets DOI Creative Commons
Qian Zhou, Yu Meng,

Jiayuan Le

и другие.

MedComm, Год журнала: 2024, Номер 5(12)

Опубликована: Ноя. 20, 2024

Ferroptosis is a nonapoptotic form of cell death characterized by iron-dependent lipid peroxidation in membrane phospholipids. Since its identification 2012, extensive research has unveiled involvement the pathophysiology numerous diseases, including cancers, neurodegenerative disorders, organ injuries, infectious autoimmune conditions, metabolic and skin diseases. Oxidizable lipids, overload iron, compromised antioxidant systems are known as critical prerequisites for driving overwhelming peroxidation, ultimately leading to plasma rupture ferroptotic death. However, precise regulatory networks governing ferroptosis ferroptosis-targeted therapy these diseases remain largely undefined, hindering development pharmacological agonists antagonists. In this review, we first elucidate core mechanisms summarize epigenetic modifications (e.g., histone modifications, DNA methylation, noncoding RNAs, N6-methyladenosine modification) nonepigenetic genetic mutations, transcriptional regulation, posttranslational modifications). We then discuss association between disease pathogenesis explore therapeutic approaches targeting ferroptosis. also introduce potential clinical monitoring strategies Finally, put forward several unresolved issues which progress needed better understand hope review will offer promise application therapies context human health disease.

Язык: Английский

Процитировано

9

Skin Metabolic Signatures of Psoriasis and Psoriasis Concurrent with Metabolic Syndrome DOI Creative Commons
Liang Yan, W Wang,

Mei-Han Dong

и другие.

Journal of Inflammation Research, Год журнала: 2025, Номер Volume 18, С. 505 - 517

Опубликована: Янв. 1, 2025

Purpose: Psoriasis is a complex inflammatory skin disorder that closely associated with metabolic syndrome (MetS). Limited information available on changes in psoriasis; the effect of concurrent MetS psoriatic metabolite levels unknown. We aimed to expand this through metabolomic analysis. Patients and Methods: Untargeted metabolomics was conducted using samples from 38 patients psoriasis vulgaris (PVMS), 23 without (PVNMS), 10 healthy controls (HC). Data analyses, including multivariate statistical analysis, KEGG pathway enrichment correlation receiver operating characteristic curve were performed. Results: Significant discrepancies found between metabolites HC PVNMS groups, particularly those involved nucleotide glycerophospholipid metabolism. Fifteen these positively correlated severity. Furthermore, affect profiles psoriasis. There some consistent alterations both PVNMS/HC PVMS/PVNMS comparisons. Conclusion: This study may provide new insights into link metabolism inflammation mechanism underlying interaction MetS. Keywords: psoriasis, syndrome, metabolomics, metabolism,

Язык: Английский

Процитировано

0

Emerging role of ferroptosis in ultraviolet radiation-driven skin photoaging: a narrative review DOI
Yan Teng, Youming Huang, Xiaohua Tao

и другие.

Photochemical & Photobiological Sciences, Год журнала: 2025, Номер unknown

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

0

Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity DOI
Ziyu Guo,

Yihuang Liu,

Danyao Chen

и другие.

Journal of Translational Internal Medicine, Год журнала: 2025, Номер 13(1), С. 10 - 32

Опубликована: Фев. 1, 2025

In the evolving landscape of cancer treatment, strategic manipulation regulated cell death (RCD) pathways has emerged as a crucial component effective anti-tumor immunity. Evidence suggests that tumor cells undergoing RCD can modify immunogenicity microenvironment (TME), potentially enhancing its ability to suppress progression and metastasis. this review, we first explore mechanisms apoptosis, necroptosis, pyroptosis, ferroptosis, cuproptosis, along with crosstalk between these modalities. We then discuss how processes activate antigen-presenting cells, facilitate cross-priming CD8+ T trigger immune responses, highlighting complex effects novel forms on TME biology. Furthermore, summarize potential drugs nanoparticles induce or inhibit emerging their therapeutic roles in treatment. Finally, put forward existing challenges future prospects for targeting anti-cancer Overall, review enhances our understanding molecular biological impacts RCD-based therapies, providing new perspectives strategies

Язык: Английский

Процитировано

0

Targeting LINC00707 by vitamin D3 attenuates nitrogen mustard-caused dermal toxicity through inhibiting ferroptosis DOI Creative Commons
Xunhu Dong, Ying He,

Xiaofeng Hu

и другие.

Redox Biology, Год журнала: 2025, Номер unknown, С. 103628 - 103628

Опубликована: Апрель 1, 2025

Nitrogen mustard (NM) causes severe skin injury that is lack of effective and targeted therapies. Vitamin D3 (VD3) emerges as a promising treatment option for NM-caused dermal toxicity; however, the underlying mechanisms are currently unclear. Herein, we identified NM markedly promoted ferroptosis by measurement decreased cell viability, glutathione, glutathione peroxidase 4 solute carrier family 7 member 11 levels, increased ROS, lipid iron/Fe2+ malondialdehyde contents in vitro vivo. Ferrostin-1 (Fer-1, inhibitor) attenuated death keratinocytes. Meanwhile, significantly inhibited phosphorylation AKT1 glycogen synthase kinase 3β (GSK3β) nuclear factor erythroid 2-related 2 (Nrf2) translocation, LINC00707 expression. Furthermore, NM-induced keratinocytes was abolished with agonists Nrf2 (tBHQ) (SC79), inhibitor GSK3β (AR-A014418), overexpression or knockdown. Mechanistically, directly bound protein domain suppressed its activated thereby inactivating Nrf2, subsequently inducing NM-treated Moreover, VD3 notably expression, inactivated GSK3β, translocation cytotoxicity induced The protective effects against toxicity were blocked erastin (a inducer), siRNA, enhanced knockdown Fer-1 In conclusion, ameliorated inhibiting ferroptosis, which partially mediated through LINC00707-AKT1-GSK3β-Nrf2 signaling pathway.

Язык: Английский

Процитировано

0

Unveiling ferroptosis: a new frontier in skin disease research DOI Creative Commons
Ke Wang,

Yumeng Lin,

Dan Zhou

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Окт. 4, 2024

Ferroptosis, a form of regulated cell death distinct from apoptosis, necrosis, and autophagy, is increasingly recognized for its role in skin disease pathology. Characterized by iron accumulation lipid peroxidation, ferroptosis has been implicated the progression various conditions, including psoriasis, photosensitive dermatitis, melanoma. This review provides an in-depth analysis molecular mechanisms underlying compares cellular effects with other forms context health disease. We systematically examine five specific diseases, ichthyosis, polymorphous light eruption (PMLE), vitiligo, melanoma, detailing influence on pathogenesis progression. Moreover, we explore current clinical landscape ferroptosis-targeted therapies, discussing their potential managing treating diseases. Our aim to shed therapeutic modulating research practice.

Язык: Английский

Процитировано

0